Viewing Study NCT04324112

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-01-22 @ 4:43 PM
Study NCT ID: NCT04324112
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2020-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hairy Cell Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEK162 View
None MEK1 View
None Inhibitor View
None MEK2 View